The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
…, G De Jesús, A Delluc, S Desai… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …
specificity for use in observational studies and trials, jointly supported by the American …
Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
…, A Alexander, M McNamara, SB Desai… - Annals of internal …, 2008 - acpjournals.org
Background: Although several agents are available to treat osteoporosis, the relative efficacy
and toxicity of these agents when used to prevent fractures has not been well described. …
and toxicity of these agents when used to prevent fractures has not been well described. …
TNFα blockade in human diseases: mechanisms and future directions
M Wong, D Ziring, Y Korin, S Desai, S Kim, J Lin… - Clinical …, 2008 - Elsevier
Tumor necrosis factor-alpha (TNFα) antagonists have shown remarkable efficacy in a variety
of immune-mediated inflammatory diseases (IMIDs). Therapeutic scope and limitations of …
of immune-mediated inflammatory diseases (IMIDs). Therapeutic scope and limitations of …
TNFα blockade in human diseases: an overview of efficacy and safety
J Lin, D Ziring, S Desai, S Kim, M Wong, Y Korin… - Clinical …, 2008 - Elsevier
Tumor necrosis factor-alpha (TNFα) antagonists including antibodies and soluble receptors
have shown remarkable efficacy in various immune-mediated inflammatory diseases (IMID). …
have shown remarkable efficacy in various immune-mediated inflammatory diseases (IMID). …
Problems encountered during anti-tumour necrosis factor therapy
SB Desai, DE Furst - Best practice & research Clinical rheumatology, 2006 - Elsevier
Worldwide, over 400 000 patients have been treated with tumour necrosis factor (TNF)-α
antagonists for indications that include rheumatoid arthritis, juvenile rheumatoid arthritis, …
antagonists for indications that include rheumatoid arthritis, juvenile rheumatoid arthritis, …
Auditory-visual speech perception in normal-hearing and cochlear-implant listeners
S Desai, G Stickney, FG Zeng - The Journal of the Acoustical Society of …, 2008 - pubs.aip.org
The present study evaluated auditory-visual speech perception in cochlear-implant users as
well as normal-hearing and simulated-implant controls to delineate relative contributions of …
well as normal-hearing and simulated-implant controls to delineate relative contributions of …
Teaching cross-cultural management: A flipped classroom approach using films
A film, as a tool for classroom learning, can be an effective teaching method to introduce
experiential learning in the cross-cultural management classroom. In cases where actual …
experiential learning in the cross-cultural management classroom. In cases where actual …
[HTML][HTML] Unwinding of a DNA triple helix by the Werner and Bloom syndrome helicases
RM Brosh, A Majumdar, S Desai, ID Hickson… - Journal of Biological …, 2001 - ASBMB
Bloom syndrome and Werner syndrome are genome instability disorders, which result from
mutations in two different genes encoding helicases. Both enzymes are members of the …
mutations in two different genes encoding helicases. Both enzymes are members of the …
PbS quantum dot sensitized anatase TiO 2 nanocorals for quantum dot-sensitized solar cell applications
Lead sulphide (PbS) quantum dot (QD) sensitized anatase TiO2 nanocorals (TNC) were
synthesized by SILAR and hydrothermal techniques. The TNC, PbS and PbS–TNC samples …
synthesized by SILAR and hydrothermal techniques. The TNC, PbS and PbS–TNC samples …
[HTML][HTML] Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study
C Ky, B Swasdibutra, S Khademi, S Desai… - Dermatology …, 2015 - ncbi.nlm.nih.gov
Cutaneous lupus erythematosus (CLE) is a chronic inflammatory autoimmune skin disease.
Evidence-based therapy for CLE is lacking in the most part. Intravenous immunoglobulin (…
Evidence-based therapy for CLE is lacking in the most part. Intravenous immunoglobulin (…